Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 374

1.

Phencyclidine-induced dysregulation of primary cilia in the rodent brain.

Shiwaku H, Umino A, Umino M, Nishikawa T.

Brain Res. 2017 Nov 1;1674:62-69. doi: 10.1016/j.brainres.2017.08.022. Epub 2017 Aug 23.

PMID:
28842124
2.

Increased DNA methylation in the parvalbumin gene promoter is associated with methamphetamine dependence.

Veerasakul S, Watiktinkorn P, Thanoi S, Dalton CF, Fachim HA, Nudmamud-Thanoi S, Reynolds GP.

Pharmacogenomics. 2017 Sep;18(14):1317-1322. doi: 10.2217/pgs-2016-0188. Epub 2017 Aug 24.

PMID:
28835159
3.

Interaction of reelin and stress on immobility in the forced swim test but not dopamine-mediated locomotor hyperactivity or prepulse inhibition disruption: Relevance to psychotic and mood disorders.

Notaras MJ, Vivian B, Wilson C, van den Buuse M.

Schizophr Res. 2017 Jul 13. pii: S0920-9964(17)30417-6. doi: 10.1016/j.schres.2017.07.016. [Epub ahead of print]

PMID:
28711473
4.

Antipsychotic-like activity of scopoletin and rutin against the positive symptoms of schizophrenia in mouse models.

Pandy V, Vijeepallam K.

Exp Anim. 2017 Jul 12. doi: 10.1538/expanim.17-0050. [Epub ahead of print]

5.

Protein Kinase Cδ Gene Depletion Protects Against Methamphetamine-Induced Impairments in Recognition Memory and ERK<sub>1/2</sub> Signaling via Upregulation of Glutathione Peroxidase-1 Gene.

Tran TV, Shin EJ, Nguyen LTT, Lee Y, Kim DJ, Jeong JH, Jang CG, Nah SY, Toriumi K, Nabeshima T, Yamada K, Kim HC.

Mol Neurobiol. 2017 Jun 9. doi: 10.1007/s12035-017-0638-8. [Epub ahead of print]

PMID:
28597397
6.

Self-inflicted enucleations: Clinical features of seven cases.

Shah M, Sun L, Elmann S, Vrcek I, Mancini R, Kim HJ, Carrasco J, Shinder R.

Orbit. 2017 Jun;36(3):154-158. doi: 10.1080/01676830.2017.1279670. Epub 2017 Mar 3.

PMID:
28594303
7.

Genetic deletion of GPR52 enhances the locomotor-stimulating effect of an adenosine A2A receptor antagonist in mice: A potential role of GPR52 in the function of striatopallidal neurons.

Nishiyama K, Suzuki H, Maruyama M, Yoshihara T, Ohta H.

Brain Res. 2017 Sep 1;1670:24-31. doi: 10.1016/j.brainres.2017.05.031. Epub 2017 Jun 3.

PMID:
28583861
8.

Investigating the Role of Serotonin in Methamphetamine Psychosis: Unaltered Behavioral Effects of Chronic Methamphetamine in 5-HT<sub>1A</sub> Knockout Mice.

Jaehne EJ, Ameti D, Paiva T, van den Buuse M.

Front Psychiatry. 2017 Apr 20;8:61. doi: 10.3389/fpsyt.2017.00061. eCollection 2017.

9.

Predicting abstinence from methamphetamine use after residential rehabilitation: Findings from the Methamphetamine Treatment Evaluation Study.

McKetin R, Kothe A, Baker AL, Lee NK, Ross J, Lubman DI.

Drug Alcohol Rev. 2017 Apr 18. doi: 10.1111/dar.12528. [Epub ahead of print]

PMID:
28421682
10.

Suppression of Methamphetamine Self-Administration by Ketamine Pre-treatment Is Absent in the Methylazoxymethanol (MAM) Rat Model of Schizophrenia.

Ruda-Kucerova J, Babinska Z, Stark T, Micale V.

Neurotox Res. 2017 Jul;32(1):121-133. doi: 10.1007/s12640-017-9718-9. Epub 2017 Apr 18.

PMID:
28421529
11.

Behavioral sensitization to methamphetamine induces specific interneuronal mRNA pathology across the prelimbic and orbitofrontal cortices.

Wearne TA, Parker LM, Franklin JL, Goodchild AK, Cornish JL.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Jul 3;77:42-48. doi: 10.1016/j.pnpbp.2017.03.018. Epub 2017 Mar 27.

PMID:
28351548
12.

Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders.

McKetin R, Baker AL, Dawe S, Voce A, Lubman DI.

Psychiatry Res. 2017 May;251:349-354. doi: 10.1016/j.psychres.2017.02.028. Epub 2017 Feb 13.

PMID:
28282630
13.

Current understanding of methamphetamine-associated dopaminergic neurodegeneration and psychotoxic behaviors.

Shin EJ, Dang DK, Tran TV, Tran HQ, Jeong JH, Nah SY, Jang CG, Yamada K, Nabeshima T, Kim HC.

Arch Pharm Res. 2017 Apr;40(4):403-428. doi: 10.1007/s12272-017-0897-y. Epub 2017 Feb 28. Review.

PMID:
28243833
14.

Factors associated with readmission in South African adolescents discharged from two inpatient psychosocial rehabilitation units.

Pieterse D, Temmingh H, Vogel W.

J Child Adolesc Ment Health. 2016 Oct;28(3):199-212. doi: 10.2989/17280583.2016.1259165.

PMID:
27998264
15.

Twelve-month course and outcome of methamphetamine-induced psychosis compared with first episode primary psychotic disorders.

Hajebi A, Amini H, Kashani L, Sharifi V.

Early Interv Psychiatry. 2016 Dec 19. doi: 10.1111/eip.12404. [Epub ahead of print]

PMID:
27991722
16.

First-Rank Symptoms in Methamphetamine Psychosis and Schizophrenia.

Shelly J, Uhlmann A, Sinclair H, Howells FM, Sibeko G, Wilson D, Stein DJ, Temmingh H.

Psychopathology. 2016;49(6):429-435. doi: 10.1159/000452476. Epub 2016 Dec 8.

PMID:
27926911
17.

Methamphetamine-related psychosis: an opportunity for assertive intervention and prevention.

Lappin JM, Sara GE, Farrell M.

Addiction. 2017 Jun;112(6):927-928. doi: 10.1111/add.13663. Epub 2016 Dec 1. No abstract available.

PMID:
27905179
18.

Increased prevalence of self-reported psychotic illness predicted by crystal methamphetamine use: Evidence from a high-risk population.

Lappin JM, Roxburgh A, Kaye S, Chalmers J, Sara G, Dobbins T, Burns L, Farrell M.

Int J Drug Policy. 2016 Dec;38:16-20. doi: 10.1016/j.drugpo.2016.10.018. Epub 2016 Nov 11.

PMID:
27842249
19.

Comprehensive behavioral study and proteomic analyses of CRMP2-deficient mice.

Nakamura H, Yamashita N, Kimura A, Kimura Y, Hirano H, Makihara H, Kawamoto Y, Jitsuki-Takahashi A, Yonezaki K, Takase K, Miyazaki T, Nakamura F, Tanaka F, Goshima Y.

Genes Cells. 2016 Oct;21(10):1059-1079. doi: 10.1111/gtc.12403. Epub 2016 Sep 1.

20.

GABAergic mRNA expression is differentially expressed across the prelimbic and orbitofrontal cortices of rats sensitized to methamphetamine: Relevance to psychosis.

Wearne TA, Parker LM, Franklin JL, Goodchild AK, Cornish JL.

Neuropharmacology. 2016 Dec;111:107-118. doi: 10.1016/j.neuropharm.2016.08.038. Epub 2016 Aug 28.

PMID:
27580848

Supplemental Content

Loading ...
Support Center